These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 11650389)
1. May a human subject waive the right to be treated as a human subject? Novick A AIDS Public Policy J; 1990; 5(1):45-8. PubMed ID: 11650389 [No Abstract] [Full Text] [Related]
2. AIDS and the FDA: an ethical case for limiting patient access to new medical therapies. Shorr AF IRB; 1992; 14(4):1-5. PubMed ID: 11651391 [No Abstract] [Full Text] [Related]
3. Faith (healing), hope and charity at the FDA: the politics of AIDS drug trials. Annas GJ Villanova Law Rev; 1989 Sep; 34(5):771-97. PubMed ID: 11651162 [No Abstract] [Full Text] [Related]
4. An overview of legal controls on human experimentation and the regulatory implications of taking Professor Katz seriously. Goldner JA St Louis Univ Law J; 1993; 38(1):63-134. PubMed ID: 11656325 [No Abstract] [Full Text] [Related]
5. Autonomy, beneficence, and the experimental subject's consent: a response to Jay Katz. Pellegrino ED St Louis Univ Law J; 1993; 38(1):55-62. PubMed ID: 11656324 [No Abstract] [Full Text] [Related]
6. Research involving the vulnerable sick. Weijer C Account Res; 1999; 7(1):21-36. PubMed ID: 11657560 [No Abstract] [Full Text] [Related]
7. Human experimentation and human rights. Katz J St Louis Univ Law J; 1993; 38(1):7-54. PubMed ID: 11656326 [No Abstract] [Full Text] [Related]
8. Making experimental drugs available for AIDS treatment. Krim M AIDS Public Policy J; 1987; 2(2):1-5. PubMed ID: 11650026 [No Abstract] [Full Text] [Related]
9. Building a new consensus: ethical principles and policies for clinical research on HIV/AIDS. Levine C; Dubler NN; Levine RJ IRB; 1991; 13(1-2):1-17. PubMed ID: 11659323 [No Abstract] [Full Text] [Related]
10. Treatments of last resort: informed consent and the diffusion of new technology. King NM; Henderson G Mercer Law Rev; 1991; 42(3):1007-50. PubMed ID: 11651433 [No Abstract] [Full Text] [Related]
11. A relational perspective on ethics-in-science decisionmaking for research with vulnerable populations. Fisher CB IRB; 1997; 19(5):1-4. PubMed ID: 11655184 [No Abstract] [Full Text] [Related]
12. Minors' assent, consent, or dissent to medical research. Leikin S IRB; 1993; 15(2):1-7. PubMed ID: 11651566 [No Abstract] [Full Text] [Related]
13. The paradoxical case of payment as benefit to research subjects. Macklin R IRB; 1989; 11(6):1-3. PubMed ID: 11650284 [No Abstract] [Full Text] [Related]
14. Decisional capacity, older human research subjects, and IRBs: beyond forms and guidelines. Kapp MB Stanford Law Pol Rev; 1998; 9(2):359-71. PubMed ID: 11657514 [No Abstract] [Full Text] [Related]
15. The case of two devices: disclosure to subjects following Phase IV ("post-marketing") research. Anderson JR; Jameton A; Reitemeier PJ; Prentice E IRB; 1995; 17(3):6-9. PubMed ID: 11654269 [No Abstract] [Full Text] [Related]
16. Legal aspects of experimentation with institutionalized mentally disabled subjects. Laves BS J Clin Pharmacol New Drugs; 1976 Part 2): 592-599, Oct; 16(10):. PubMed ID: 11664683 [No Abstract] [Full Text] [Related]
17. Balancing moral principles in federal regulations on human research. Ackerman TF IRB; 1992; 14(1):1-6. PubMed ID: 11652041 [No Abstract] [Full Text] [Related]
18. Regulation of drug treatments for HIV and AIDS: a contractarian model of access. Salbu SR Yale J Regul; 1994; 11(2):401-53. PubMed ID: 11660141 [No Abstract] [Full Text] [Related]
19. Considering behavioral and biomedical research on detainees in the mental health unit of an urban mega-jail. Brakel SJ N Engl J Crim Civ Confin; 1996; 22(1):1-27. PubMed ID: 11660427 [No Abstract] [Full Text] [Related]
20. Patients, agents, and informed consent. Haber JG J Law Health; 1985-1986; 1():43-59.. PubMed ID: 11658933 [No Abstract] [Full Text] [Related] [Next] [New Search]